The results of CardinALS showed utreloxastat failed to meet its main and secondary goals, including several disease-related ...

Neuralink's brain-computer interface will be tested in Canada, with Toronto's University Health System seeking patients for ...

The Phase 1 trial ANQUR, now testing two new doses of the ALS therapy QRL-201, is enrolling patients at 12 sites in Canada ...

Scientists studied 188 people related to someone with ALS caused by a C9ORF72 mutation to identify markers of disease risk in ...

Columnist Kristin Neva recognizes the distinction between being thankful "in" a bad situation rather than "for" a bad situation.

Columnist Dagmar Munn has a Santa wish list for her outings over the holidays: accessible restrooms and good cutlery among ...

Widetrial, an integrated service and technology platform, is coming on board to support an expanded access program (EAP) that will provide the investigational therapy MN-166 (ibudilast) to amyotrophic ...